Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 45.90
-0.20 (-0.43%)
Sep 30, 2026, 1:30 PM CST
Orient EuroPharma Market Cap
Orient EuroPharma has a market cap or net worth of 4 billion as of September 29, 2026. Its market cap has decreased by -7.34% in one year.
Market Cap
4.00B
Enterprise Value
6.99B
Revenue
4.65B
Ranking
n/a
PE Ratio
n/a
Stock Price
45.90
ChartMarket Cap Chart
Since November 3, 2004, Orient EuroPharma's market cap has increased from 700.81M to 4.00B, an increase of 470.63%. That is a compound annual growth rate of 8.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 4.00B | 2.90% |
| Dec 31, 2025 | 3.89B | -7.05% |
| Dec 31, 2024 | 4.18B | 23.91% |
| Dec 29, 2023 | 3.37B | 7.46% |
| Dec 30, 2022 | 3.14B | -0.41% |
| Dec 30, 2021 | 3.15B | -24.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.78B |
| Alar Pharmaceuticals | 6.60B |
| Yoda Pharmaceuticals | 6.00B |
| Orient Pharma | 5.83B |
| Formosa Laboratories | 5.78B |
| LIWANLI Innovation | 4.71B |
| Panion & Bf Biotech | 4.60B |
| Easywell Biomedicals | 3.60B |